Overview

Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
* Adding Amantadine to standard anti-viral treatment can improve sustained response rates in patients with chronic hepatitis C
Phase:
Phase 3
Details
Lead Sponsor:
UMC Utrecht
Treatments:
Amantadine
Interferon-alpha
Interferons
Ribavirin